• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Controlled release microparticles for vaccine development.

作者信息

O'Hagan D T, Jeffery H, Roberts M J, McGee J P, Davis S S

机构信息

Department of Pharmaceutical Sciences, University of Nottingham, University Park, UK.

出版信息

Vaccine. 1991 Oct;9(10):768-71. doi: 10.1016/0264-410x(91)90295-h.

DOI:10.1016/0264-410x(91)90295-h
PMID:1759495
Abstract

The primary and secondary sera IgG antibody responses to ovalbumin (OVA) entrapped in biodegradable poly(lactide-co-glycolide) (PLGA) microparticles were compared with the responses obtained with soluble OVA. In addition, OVA in PLGA microparticles was also administered after dispersion in an immunostimulatory vehicle, Freund's incomplete adjuvant (FIA). The primary IgG responses to OVA in microparticles/FIA were significantly greater than the responses to soluble OVA from day 14 to day 42, when booster immunizations were administered. From day 49 to the end of the study at day 84, the responses to OVA, both in microparticles alone and in microparticles/FIA, were significantly greater than the responses to soluble OVA. Nevertheless, the responses obtained for OVA in microparticles or microparticles/FIA were, in general, not as high as those obtained with OVA in Freund's complete adjuvant.

摘要

相似文献

1
Controlled release microparticles for vaccine development.
Vaccine. 1991 Oct;9(10):768-71. doi: 10.1016/0264-410x(91)90295-h.
2
Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.用包裹在可生物降解微粒中的卵清蛋白对小鼠进行皮下免疫后的长期抗体反应。
Vaccine. 1993;11(9):965-9. doi: 10.1016/0264-410x(93)90387-d.
3
Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.以卵清蛋白为疫苗制剂的聚(丙交酯-乙交酯)微球的口服给药:粒径研究
Biol Pharm Bull. 1994 Sep;17(9):1272-6. doi: 10.1248/bpb.17.1272.
4
Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.基于二氨基硫化物的聚合物微粒作为癌症疫苗递送系统。
J Control Release. 2015 Dec 28;220(Pt B):682-90. doi: 10.1016/j.jconrel.2015.09.002. Epub 2015 Sep 8.
5
Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.以含有卵清蛋白作为疫苗制剂的聚(丙交酯-乙交酯)微球进行皮下给药的粒径研究。
J Pharm Pharmacol. 1995 Jul;47(7):556-60. doi: 10.1111/j.2042-7158.1995.tb06713.x.
6
Biodegradable microparticles as controlled release antigen delivery systems.可生物降解微粒作为控释抗原递送系统。
Immunology. 1991 Jun;73(2):239-42.
7
Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.用包裹在聚(丙交酯-乙交酯)微粒中的卵清蛋白免疫诱导黏膜和全身免疫反应。
Immunology. 1994 Apr;81(4):661-7.
8
Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen.单剂量、基于聚合物微粒的疫苗:制剂条件对蛋白质抗原免疫反应的强度和持续时间的影响。
Vaccine. 1996 Oct;14(15):1429-38. doi: 10.1016/s0264-410x(96)00077-1.
9
PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.使用肠溶包衣聚合物稳定化的纤溶酶原微粒作为口服疫苗递送系统。
Vaccine. 1999 Jul 16;17(22):2927-38. doi: 10.1016/s0264-410x(99)00140-1.
10
The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.基于丙交酯聚合物和聚乙二醇共混物的可生物降解微粒中包裹的蛋白质抗原的稳定性和免疫原性。
Vaccine. 1999 Feb 12;17(6):512-29. doi: 10.1016/s0264-410x(98)00229-1.

引用本文的文献

1
Potential of DPD ((S)-4,5-dihydroxy-2,3-pentanedione) Analogs in Microparticulate Formulation as Vaccine Adjuvants.微颗粒制剂形式的DPD((S)-4,5-二羟基-2,3-戊二酮)类似物作为疫苗佐剂的潜力。
Pharmaceuticals (Basel). 2024 Jan 30;17(2):184. doi: 10.3390/ph17020184.
2
Modeling the kinetics of lymph node retention and exposure of a cargo protein delivered by biotin-functionalized nanoparticles.通过生物素功能化纳米颗粒递送来模拟货物蛋白在淋巴结中的保留和暴露的动力学。
Acta Biomater. 2023 Oct 15;170:453-463. doi: 10.1016/j.actbio.2023.08.048. Epub 2023 Aug 29.
3
The Autoinducer N-Octanoyl-L-Homoserine Lactone (C8-HSL) as a Potential Adjuvant in Vaccine Formulations.
自诱导剂N-辛酰基-L-高丝氨酸内酯(C8-HSL)作为疫苗制剂中的潜在佐剂
Pharmaceuticals (Basel). 2023 May 8;16(5):713. doi: 10.3390/ph16050713.
4
Dynamic Covalent Dextran Hydrogels as Injectable, Self-Adjuvating Peptide Vaccine Depots.动态共价葡聚糖水凝胶作为可注射、自佐剂的肽疫苗储存库。
ACS Chem Biol. 2023 Mar 17;18(3):652-659. doi: 10.1021/acschembio.2c00938. Epub 2023 Feb 17.
5
Facile synthesis of multi-faceted, biomimetic and cross-protective nanoparticle-based vaccines for drug-resistant Shigella: a flexible platform technology.多面仿生且具有交叉保护作用的基于纳米颗粒的耐药福氏志贺菌疫苗的简便合成:一种灵活的平台技术。
J Nanobiotechnology. 2023 Jan 29;21(1):34. doi: 10.1186/s12951-023-01780-y.
6
Immune Cells Activating Biotin-Decorated PLGA Protein Carrier.免疫细胞激活生物素修饰的 PLGA 蛋白载体。
Mol Pharm. 2022 Jul 4;19(7):2638-2650. doi: 10.1021/acs.molpharmaceut.2c00343. Epub 2022 May 27.
7
Considerations for Size, Surface Charge, Polymer Degradation, Co-Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases.传染病聚合物颗粒疫苗开发中尺寸、表面电荷、聚合物降解、共递送及可制造性的考量因素
Adv Nanobiomed Res. 2021 Mar;1(3):2000041. doi: 10.1002/anbr.202000041. Epub 2021 Jan 18.
8
PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.用于亚单位疫苗的聚乳酸-羟基乙酸共聚物微粒递送系统:将颗粒特性与免疫原性联系起来。
Hum Vaccin Immunother. 2016 Apr 2;12(4):1056-69. doi: 10.1080/21645515.2015.1117714. Epub 2016 Jan 11.
9
Nanodelivery Systems as New Tools for Immunostimulant or Vaccine Administration: Targeting the Fish Immune System.纳米递送系统作为免疫刺激剂或疫苗给药的新工具:靶向鱼类免疫系统
Biology (Basel). 2015 Oct 19;4(4):664-96. doi: 10.3390/biology4040664.
10
Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity.将鼠疫耶尔森氏菌 F1 抗原与金纳米颗粒结合可提高免疫原性。
Vaccine. 2012 Nov 6;30(48):6777-82. doi: 10.1016/j.vaccine.2012.09.021. Epub 2012 Sep 18.